Physician profile
Caleb Warner Smith
NPI 1164159471
$1,040.10
in general payments reported to CMS, 2019-2025
17 companies · $15.39 in 2025
The $15.39 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $61.15 · 2023: $859 · 2024: $104 · 2025: $15.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $978.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $468.47 | 2022-2025 | |
| Ironwood Pharmaceuticals, INC | $105.26 | 2023 | Linzess |
| Nestle Healthcare Nutrition INC. | $67.42 | 2023 | |
| Ferring Pharmaceuticals INC. | $64.27 | 2023 | Rebyota |
| Takeda Pharmaceuticals U.S.A., INC. | $46.52 | 2022-2023 | Entyvio |
| Merck Sharp & Dohme LLC | $42.85 | 2023 | Dificid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.92 | 2023 | Trulance, Xifaxan |
| Janssen Pharmaceuticals, INC | $33.31 | 2024 | Xarelto |
| Gilead Sciences, INC. | $25.48 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $23.76 | 2023 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.61 | 2023 | Cyltezo |
| Janssen Biotech, INC. | $19.23 | 2023 | Stelara |
| Ardelyx, INC. | $19.05 | 2023 | Ibsrela |
| Celgene Corporation | $16.97 | 2022 | |
| Pfizer INC. | $16.24 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14.58 | 2023 | Gi Genius |
| Qol Medical, LLC | $14.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.